Literature DB >> 22593245

In silico functional profiling of individual prostate cancer tumors: many genes, few functions.

Ivan P Gorlov1, Jinyoung Byun, Christopher J Logothetis.   

Abstract

BACKGROUND: Identification of genes that are differently expressed is a common approach used to analyze genetic mechanisms underlying cancer development. However, recent study results suggest that many such genes relate to a small number of biological functions. We hypothesized that analysis of these functions provides a better understanding of tumor biology than does actual identification of these genes.
MATERIALS AND METHODS: We re-analyzed publicly available gene expression data for paired samples of prostate tumor and adjacent normal tissue from the same patients to identify genes differently expressed in individual tumors and then used them to identify the functions.
RESULTS: We found significant interindividual variation in the type and the number of functions. After adjusting for redundancy and nonspecificity of the functional terms, we identified seven functions. Several of them showed a strong association with clinical traits, e.g. age at diagnosis, preoperative prostate-specific antigen concentration, Gleason grade, and biochemical recurrence. Actin cytoskeleton was the function most frequently associated with clinical traits. Of note, the association between function and clinical traits was much stronger than that between the genes differently expressed and those traits.
CONCLUSION: Different prostate tumors differ in their functional profiles. Functions of differently expressed genes are strongly associated with clinical traits. This suggests that analysis of functions of differently expressed genes may provide a better description of tumor biology than does analysis of the respective genes.

Entities:  

Mesh:

Year:  2012        PMID: 22593245      PMCID: PMC3922615     

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  22 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Significance of talin in cancer progression and metastasis.

Authors:  Andreas Desiniotis; Natasha Kyprianou
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

Review 3.  Hallmarks of cancer: interactions with the tumor stroma.

Authors:  Kristian Pietras; Arne Ostman
Journal:  Exp Cell Res       Date:  2010-03-06       Impact factor: 3.905

4.  Integrative genomic profiling of human prostate cancer.

Authors:  Barry S Taylor; Nikolaus Schultz; Haley Hieronymus; Anuradha Gopalan; Yonghong Xiao; Brett S Carver; Vivek K Arora; Poorvi Kaushik; Ethan Cerami; Boris Reva; Yevgeniy Antipin; Nicholas Mitsiades; Thomas Landers; Igor Dolgalev; John E Major; Manda Wilson; Nicholas D Socci; Alex E Lash; Adriana Heguy; James A Eastham; Howard I Scher; Victor E Reuter; Peter T Scardino; Chris Sander; Charles L Sawyers; William L Gerald
Journal:  Cancer Cell       Date:  2010-06-24       Impact factor: 31.743

5.  Does TGF-β induced formation of actin stress fibres reinforce Smad dependent TGF-β signalling in the prostate?

Authors:  Stephen Assinder; Nicholas Cole
Journal:  Med Hypotheses       Date:  2011-03-21       Impact factor: 1.538

6.  PSK, a novel STE20-like kinase derived from prostatic carcinoma that activates the c-Jun N-terminal kinase mitogen-activated protein kinase pathway and regulates actin cytoskeletal organization.

Authors:  T M Moore; R Garg; C Johnson; M J Coptcoat; A J Ridley; J D Morris
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

7.  PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion.

Authors:  Claire M Wells; Andrew D Whale; Maddy Parsons; John R W Masters; Gareth E Jones
Journal:  J Cell Sci       Date:  2010-04-20       Impact factor: 5.285

8.  Alterations in beta-catenin expression and localization in prostate cancer.

Authors:  Hayley C Whitaker; Joanne Girling; Anne Y Warren; Hing Leung; Ian G Mills; David E Neal
Journal:  Prostate       Date:  2008-08-01       Impact factor: 4.104

9.  Changes in cortical cytoskeletal and extracellular matrix gene expression in prostate cancer are related to oncogenic ERG deregulation.

Authors:  Wolfgang A Schulz; Marc Ingenwerth; Carolle E Djuidje; Christiane Hader; Jörg Rahnenführer; Rainer Engers
Journal:  BMC Cancer       Date:  2010-09-22       Impact factor: 4.430

10.  GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an example.

Authors:  Ivan P Gorlov; Gary E Gallick; Olga Y Gorlova; Christopher Amos; Christopher J Logothetis
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

View more
  2 in total

1.  AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination.

Authors:  Michael C Haffner; David M Esopi; Alcides Chaux; Meltem Gürel; Susmita Ghosh; Ajay M Vaghasia; Harrison Tsai; Kunhwa Kim; Nicole Castagna; Hong Lam; Jessica Hicks; Nicolas Wyhs; Debika Biswal Shinohara; Paula J Hurley; Brian W Simons; Edward M Schaeffer; Tamara L Lotan; William B Isaacs; George J Netto; Angelo M De Marzo; William G Nelson; Steven S An; Srinivasan Yegnasubramanian
Journal:  Nat Commun       Date:  2017-07-26       Impact factor: 14.919

2.  The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis.

Authors:  Jacek Marzec; Helen Ross-Adams; Stefano Pirrò; Jun Wang; Yanan Zhu; Xueying Mao; Emanuela Gadaleta; Amar S Ahmad; Bernard V North; Solène-Florence Kammerer-Jacquet; Elzbieta Stankiewicz; Sakunthala C Kudahetti; Luis Beltran; Guoping Ren; Daniel M Berney; Yong-Jie Lu; Claude Chelala
Journal:  Cancers (Basel)       Date:  2021-01-19       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.